SlideShare una empresa de Scribd logo
1 de 48
Descargar para leer sin conexión
S A L I VA
A S A
D I A G N O S T I C F L U I D
D R A M I T H A G
D E P T O F O R A L A N D M A X I L L O FA C I A L PAT H O L O G Y
CONTENTS :
• Definition
• General properties
• Composition
• Function of saliva
• Formation of saliva
• Method for collecting saliva
• Advantages
• Limitations
• Analysis of saliva done for the diagnosis of systemic disease
Definition:
by Stedmann’s & Lipincott medical dictionary.
A clear, tasteless, odourless, slightly acidic (pH 6.8) viscous fluid,
consisting of the secretion from the parotid, sublingual, submandibular
salivary glands and the mucous glands of the oral cavity.
General properties
• Volume: 1000 to 1500 mL of saliva is secreted per day and, it is
approximately about 1 ml/ minute.
• Contribution by each major salivary gland is:
i. Parotid glands: 25%
ii. Submandibular glands: 70%
iii. Sublingual glands: 5%.
• Reaction: Mixed saliva from all the glands is slightly acidic with pH of
6.35 to 6.85.
• Specific gravity: It ranges between 1.002 and 1.012.
• Tonicity: Saliva is hypotonic.
Salivary flow
• The average person produces approximately 0.5 L – 1.5 L per day
Unstimulated Flow (resting salivary flow―no external stimulus)
• Typically 0.2 mL – 0.3 mL per minute
Stimulated Flow (response to a stimulus, usually taste, chewing, or
medication [eg, at mealtime])
• Typically 1.5 mL – 2 mL per minute
COMPOSITION
saliva contains 99.5% water and 0.5%solids.
Ten Cate’s Oral Histology
Ten Cate’s Oral Histology
FUNCTIONS OF SALIVA
1. PROTECTION
• Fluid nature of saliva provides a washing action that flushes away non adherent bacteria
and other debris.
• Helps in clearance of sugars from the mouth limits their availability to acidogenic plaque
microorganisms.
• Mucins and other glycoproteins provide lubrication, preventing the oral tissues from
adhering to one another and allowing them to slide easily over one another.
• Mucins also form a barrier against noxious stimuli, microbial toxins, and minor trauma.
Ten Cate’s Oral Histology
2. BUFFERING
• Bicarbonate and phosphate ions provide a buffering action that helps to
protect the teeth from demineralization caused by bacterial acids
produced during sugar metabolism.
• Some basic salivary proteins also may contribute to the buffering action
of saliva.
• The metabolism of salivary proteins and peptides by bacteria produces
urea and ammonia, which help to increase the pH.
3. PELLICLE FORMATION
• Many of the salivary proteins bind to the surfaces of the teeth and oral
mucosa, forming a thin film, the salivary pellicle.
• Proteins bind calcium and help to protect the tooth surface.
• Others have binding sites for oral bacteria, providing the initial attachment
for organisms that form plaque.
4. MAINTENANCE OF TOOTH INTEGRITY
• Saliva is supersaturated with calcium and phosphate ions.
• The solubility of these ions is maintained by several calcium- binding
proteins, especially the acidic proline-rich proteins and statherin.
• At the tooth surface the high concentration of calcium and phosphate results
in a posteruptive maturation of the enamel, increasing surface hardness and
resistance to demineralization.
• Remineralization of initial caries lesions can occur; this is enhanced by the
presence of fluoride ions in saliva.
5. ANTIMICROBIAL ACTION
• Saliva contains a spectrum of proteins with antimicrobial activity such as the lysozyme,
lactoferrin, peroxidase, and secretory leukocyte protease inhibitor.
• A number of small peptides include α-defensins and β-defensins, cathelicidin-
LL37,histatins that function by inserting into membranes and disrupting cellular or
mitochondrial functions are present in saliva.
• These proteins and peptides exhibit antibacterial, antifungal and antiviral activity.
• Secretory immunoglobulin A (IgA), causes agglutination of specific microorganisms,
preventing their adherence to oral tissues and forming clumps that are swallowed.
6. TISSUE REPAIR
• A variety of growth factors and other biologically active peptides and
proteins are present in small quantities in saliva.
• Many of these substances promote tissue growth and differentiation,
wound healing.
7. DIGESTION
• The solubilization of food substances and the actions of enzymes such as
amylase and lipase begin the digestive process.
• The moistening and lubricative properties of saliva also allow the formation
and swallowing of a food bolus.
8. TASTE
• Saliva solubilize food substances so that they can be sensed by taste
receptors located in taste buds.
• Saliva produced by minor glands in the vicinity of the circumvallate
papillae contains proteins that are believed to bind taste substances and
present them to the taste receptors.
Formation of saliva occurs in 2 stages.
Stage 1 : Production of primary saliva from the cells of
secretory end pieces & intercalated ducts, which is an
isotonic fluid
Stage 2 : The primary saliva is modified as it passes through
the striated & excretory ducts mainly by reabsorption &
secretion of electrolytes.
The final saliva that reaches the oral cavity is hypotonic.
FORMATION AND SECRETION OF SALIVA
Formation of saliva
• acinar cells produce initial saliva composed of water, ions, enzymes, and
mucus
• initial saliva is isotonic and has approximately same osmolarity as plasma
• initial saliva passes from acinus to duct
• ductal cells modify initial saliva to produce final saliva by altering various
electrolyte concentrations
• ductal cells absorb Na+ and Cl-, decreasing ion concentrations in saliva
• ductal cells secrete K+ and HCO3
-, increasing ion concentrations in saliva
• salivary HCO3
- neutralizes oral bacterial acids
• maintains dental health
• final saliva is hypotonic and has lower osmolarity than plasma
http://www.medbullets.com/step1-gastrointestinal/10023/salivary-secretion
Regulation of salivary secretion
salivary secretion is stimulated by both sympathetic and parasympathetic nervous systems
• sympathetic nervous system
• sympathetic input to salivary glands originates in thoracic segments T1-T3 with preganglionic nerves
that synapse in superior cervical ganglion
• postganglionic sympathetic neurons release norepinephrine (NE)
• ↑ NE → stimulates β-adrenergic receptors → stimulates adenylyl cyclase → ↑ cAMP → ↑ saliva
secretion
• parasympathetic nervous system
• parasympathetic input to salivary glands originates in facial nerve (CN VII) and glossopharyngeal nerve
(CN IX)
• postganglionic parasympathetic neurons release ACh
• ↑ ACh → stimulates muscarinic receptors → ↑ IP3 and Ca2+ → ↑ saliva secretion
parasympathetic activity stimulated by food, smell, nausea, and conditioning
parasympathetic activity inhibited by dehydration, fear, and sleep
http://www.medbullets.com/step1-gastrointestinal/10023/salivary-secretion
FORMATION AND SECRETION OF SALIVA
• Protein secretion occurs by exocytosis, that is, the fusion of
secretory granules with the luminal membrane to release
their contents into the lumen.
• The binding of the sympathetic transmitter norepinephrine
(NE) to β-adrenergic (β) receptors on the basolateral
membrane activates a heterotrimeric G-protein (Gs), which
in turn activates adenylyl cyclase (AC), catalyzing the
formation of cyclic adenosine monophosphate (cAMP)
from adenosine triphosphate (ATP).
• Cyclic adenosine monophosphate activates protein kinase A
(PKA), which phosphorylates other proteins in a cascade
leading to exocytosis.
Ten Cate’s Oral Histology
• Fluid and electrolyte secretion is stimulated mainly by the
binding of the parasympathetic transmitter, acetylcholine
(ACh) to muscarinic cholinergic (MC) receptors and also
by norepinephrine binding to α-adrenergic receptors (α).
• These receptors activate a heterotrimeric G-protein
(Gq/11), causing activation of phospholipase C (PLC),
which converts phosphatidylinositol bisphosphate (PIP2)
to inositol trisphosphate (IP3) and diacylglycerol (DAG).
• Inositol trisphosphate causes the release of Ca2+ from
intracellular stores, probably the endoplasmic reticulum.
The increased Ca2+ concentration opens Cl– channels in
the luminal membrane and K+ channels in the basolateral
membrane and activates the basolateral Na+/K+/2Cl–
cotransporter.
• The increased luminal Cl– is balanced by the movement of
extracellular Na++ across the tight junctions (TJ), and the
resulting osmotic gradient pulls water into the lumen
through the cell via the water channel aquaporin 5 and
through the tight junction.
• The basolateral Na+/K+/2Cl– cotransporter and the
Na+/K+–adenosine triphosphatase serve to maintain the
intracellular electrolyte and osmotic balances.
• Calcium also stimulates exocytosis, but to a lesser extent
than cyclic adenosine monophosphate, and it modulates the
activity of protein kinase A and protein kinase C (PKC).
Protein kinase C, in turn, modulates exocytosis and
intracellular Ca2+ concentrations.
Instructions for Collecting Saliva:
1.Remove cap from cryovial
2.Remove Saliva Collection Aid from packaging and place securely into cryovial.
3.Instruct participants to allow saliva to pool in the mouth.
4.With head tilted forward, participants should drool through the SCA to collect saliva in
the cryovial.
5.Repeat until sufficient sample is collected. Reserve air space in the vial to accommodate
the expansion of saliva during freezing. Collection of samples to be analyzed for multiple
analytes may require additional cryovials.
6.Replace cap onto cryovial.
How to Collect Saliva: Collection Methods and Devices
Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC
The Salimetrics Oral Swab (SOS)
• If participants are not willing or able to drool saliva into a vial.
• If the saliva samples are to be analyzed for cortisol, testosterone, α-amylase,
chromogranin A, C-reactive protein, or SIgA, the Salimetrics Oral Swab (SOS) is an
excellent alternative to passive drool because of its ease of use.
• The SOS also helps filter mucus and other matter from the sample, which may help
improve immunoassay results.
Collection Methods and Devices:
Infants and Small Children
The Children’s Swab and Infant’s Swab
We recommend the SalivaBio Children’s Swab (SCS) for children under the age of 6,
and the SalivaBio Infant’s Swab (SIS) for infants under 6 months of age.
The extra-length SalivaBio Children’s Swab (SCS) may also be used for saliva collection
from infirmed adult patients to avoid any danger of choking.
All SalivaBio swabs are made from the same non-toxic, inert polymer which is
guaranteed for consistency across all lots, making it ideal for longitudinal and multi-
participant group studies.
These devices are manufactured in longer lengths and narrower widths to allow one end
of the swab to be held by a parent or technician while the other end is placed in the
child’s mouth.
The diameters are appropriate for the size of children’s mouths.
The polymer material is durable and can withstand chewing, and its taste and texture are
also acceptable to children.
The volume of sample recovered from the SCS and SIS is typically in the range of 200-
1000 μL. Like the adult SOS, samples collected with either the SCS or the SIS may be
tested for various analytes
• Passive drool is highly recommended because it is both cost effective and approved for
use with almost all analytes.
• If participants are not willing or able to drool saliva into a vial, the SalivaBio Oral Swab
may be used as an alternative collection method, but only for certain analytes
• To avoid problems with analyte retention or the introduction of contaminants, use only
high quality polypropylene vials for collection, such as 2 ml cryovials.
• The vials used must seal tightly, must be able to withstand temperatures down to -80oC,
and must be externally threaded to allow for use of the Saliva Collection Aid to
effectively guide drool directly into the cryovial.
Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC
Advantages
1. Noninvasive diagnosis of disease and monitoring of general health.
2. Painless, patient suffers no discomfort and little anxiety in the collection process.
3. Simple in collection with a modest trained assistant and applicable in remote
areas.
4. Relatively cheap technology as compared to other tests.
5. Cost effective applicability for screening large population.
6. Can be used to study special population where blood sampling is a problem e.g
children, anxious /handicap/ elderly patients.
7. Convenient for multisampling.
8. Safer for health professionals than blood tests.
9. Compared to blood and urine, saliva is also cheaper to store and ship.
10. In addition saliva does not clot and can be manipulated more easily than blood.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11, Issue 6 (Nov.- Dec.
2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr Shrinivas M Basavaraddi,Dr Krishna
Burde, Dr Priya Horatti
Limitations:
1. Levels of certain markers in saliva are not always a reliable reflection of the levels of
these markers in serum.
2. Salivary composition can be influenced by the method of collection and degree of
stimulation of salivary flow.
3. Changes in salivary flow rate may affect the concentration of salivary markers and
also their availability due to changes in salivary pH.
4. Variability in salivary flow rate is expected between individuals and in the same
individual under different conditions.
6. In addition, many serum markers can reach whole saliva in an unpredictable way
(i.e. gingival cervical fluid flow and through oral wounds). These parameters will
affect the diagnostic usefulness of many salivary constituents.
7. Furthermore, certain systemic disorders, numerous medications and radiation may
affect salivary gland function and consequently the quantity and composition of
saliva.
8. Whole saliva also contains proteolytic enzymes derived from the host and from oral
microorganisms. These enzymes can affect the stability of certain diagnostic
markers. Some molecules are also degraded during intracellular diffusion into
saliva.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11, Issue 6 (Nov.- Dec.
2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr Shrinivas M Basavaraddi,Dr Krishna
Burde, Dr Priya Horatti
Analysis of saliva done for the diagnosis of following
Hindawi Publishing Corporation. ISRN Dentistry. Volume 2014, Article ID 158786, 8 pages. http://dx.doi.org/10.1155/2014/158786 .
Review Article . Salivary Diagnostics: A Brief Review. Narasimhan Malathi,1 Sabesan Mythili,1 and Hannah R. Vasanthi2
Potential Biomarkers in Saliva
1. Autoimmune Diseases
A. Sjogren’s Syndrome (SS)
• It is an autoimmune disorder characterized by reduced secretion of the salivary glands and
lacrimal glands and associated endocrine disturbance. Sialochemistry offers great value in
the diagnosis of SS.
• An increase in the levels of immunoglobulins, inflammatory mediators, albumin, sodium,
and chloride and a decrease in the level of phosphate are indicative of SS.
• Salivary protein analysis demonstrated an increased level of lactoferrin, beta 2
microglobulin, lysozyme C, and cystatin C.
• The levels of salivary amylase and carbonic anhydrase were decreased.
B. Multiple Sclerosis
• Multiple sclerosis (MS) is an inflammatory disease characterized by loss of
myelin and scarring caused due to destruction/failure of myelin producing
cells by the immune system.
• Salivary diagnostics shows no significant change in the saliva of patients
with multiple sclerosis except for a reduction in IgA production
C. Sarcoidosis
Sarcoidosis is an inflammatory disease of the lymph nodes, lungs, liver, eyes,
skin, or other tissues.
Salivary diagnostics demonstrates a decrease in the secretion volume of saliva
in addition to a reduction in the enzyme activity of alpha-amylase and
kallikrein in most of these patients.
However, there was no correlation between the decrease in the enzyme activity
and the secretion volume
2. Dental Caries and Periodontal Diseases.
• The increased numbers of Streptococcus mutans and lactobacilli in saliva have been
associated with increased caries prevalence and root caries.
• Periodontal diseases have been associated with increased levels of aspartate
aminotransferase (AST) and alkaline phosphatase (ALP).
• Salivary AST can be used as a marker for monitoring periodontal disease.
• Lower levels of uric acid and albumin were associated with periodontitis and diabetes.
This could be attributed to the oxidative stress present in the oral cavity during these
conditions.
• In patients with type 2 diabetes mellitus, the salivary expression of pIgR, Arp 3, CA VI,
and IL-1Ra was down- regulated, whereas PLS-2, LEI, and IGJ chain appeared to be
upregulated
Diagnostic Applications of Saliva in Dentistry 1Prabhakar AR, 2Akanksha Gulati, 3Deepak Mehta, 4Sugandhan S
3. Malignancy
• Tang et al. - lncRNA , p53 protein and miRNAs, - oral squamous cell carcinoma
(OSCC)
• Salivary lactate dehydrogenase, Salivary cortisol, salivary nitrate and nitrite levels
increased - oral cancer
• Salivary adenosine deaminase (ADA) activity is significantly increased in squamous
cell carcinoma of the tongue progressively from stage I to stage III.
• Fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 1 (FGFR1)
concentrations in saliva are significantly elevated - salivary gland tumors
• Salivary mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, CA 125 and GREB1) - lung
cancer
• AGPAT1, B2M, BASP2, IER3, and IL1B, CA 125 - ovarian cancer
• CA15-3, CA 125 - breast cancer.
4. Bone Turnover Markers:
• Saliva can be used in mass screening for metabolic bone disorder.
• Human saliva was analysed and there is a significant correlations have been reported
between age, body mass index, deoxypyridinium (D-PYR) and osteocalcin (OC)
concentration and calcaneus T scores.
• This suggests that saliva could be used as a fluid for assay of human biomarkers of bone
turnover.
• Scannapieco et al. noted a positive association between alveolar bone loss and salivary
concentrations of hepatocyte growth factor and interleukin-1 beta. However, there was a
negative association between alveolar bone loss and salivary osteonectin.
• The increased levels of alkaline phosphatase (ALP) activity in periodontitis have been
correlated with the alveolar bone loss
5. Drug Level Monitoring
• Saliva is used to detect the presence of nicotine to monitor exposure to tobacco smoke,
cannabinoids, cocaine, phencyclidine, opioids, barbiturates, diazepines, amphetamines, and
ethanol.
• In drug level monitoring, only the unbound fraction of the drug in serum diffuses into the
saliva and is detectable in the saliva.
• Rapid detection of illicit drug use can also be done through the direct analysis of
methamphetamine, cocaine, and 3,4-methylenedioxymethamphetamine in saliva by a
hydrophobic porous silicon array.
• Saliva is a biological matrix used for drug testing of 𝛾- hydroxybutyric acid (GHB) levels
because of its merit of easy, noninvasive collection and stability of the drug. Also, the values
of the drug in saliva correlate with its level in the blood
6. Genetic Disorders
A. Cystic Fibrosis:
• Cystic fibrosis (CF) is a genetically determined condition which is caused due to a
mutation in the CFTR gene.
• The CFTR protein is expressed in the epithelial cells of the parotid gland causing
parotid gland involvement.
• The level of activity of cathepsin-D in saliva is significantly higher
• The values of sodium, potassium, and chloride concentrations is significantly higher
• Salivary calcium concentration, magnesium concentration, and lactate dehydrogenase
levels is increased.
B. Ectodermal Dysplasia:
• The most common form of ectodermal dysplasia is the X-linked hypohidrotic
ectodermal dysplasia (HED).
• Lexner et al. performed a study on whole saliva flow and composition in males
affected by HED and the female carriers.
• He found that there was reduced whole saliva flow and the concentration of
inorganic constituents and total protein was high.
• However, the activity and the concentration of the alpha-amylase in the saliva were
reduced
7. Cardiovascular Diseases.
• Salivary markers of cardiovascular diseases include C-reactive protein (CRP), myoglobin (MYO),
creatinine kinase myocardial band (CK- MB), cardiac troponins (cTn), and myeloperoxidase, which, when
used in combination with an ECG, shows a positive correlation with myocardial infarct patients as
compared to healthy controls.
• The salivary MYO levels are significantly higher within 48 h of onset of chest pain in acute myocardial
infarction (AMI) patients.
• In a study performed by Miller et al.,
In AMI they found that the salivary concentrations of CRP, TNF-𝛼, and MMP-9 were higher
salivary myeloperoxidase and salivary soluble ICAM-1levels elevated
salivary soluble CD40 ligand is lower
• Increased levels of salivary lysozyme have been shown to be associated with hypertension, an early stage
of cardiovascular disorders
8. Infections
(1) Viral infections : Measles virus-specific IgM,
HIV—HIV-1, HIV-2—antibodies, salivary proteins
(2) Bacterial infections : Mycobacterium tuberculosis, MUC 5B, and MUC 7
(3) Fungal infections : Candidiasis immunoglobulins, Hsp 70, and calprotectin,
histatins, mucins, basic proline rich proteins, and peroxidases
9. Psychological research
Salivary amylase, cortisol, substance P, lysozyme, secretory IgG, and
testosterone
10. Renal diseases
Cortisol, nitrite, uric acid, sodium chloride, pH, alpha-amylase, and
lactoferrin. Salivary phosphate, serum creatinine, and glomerular
ltration rate
11. Diseases of the adrenal cortex
Salivary cortisol
Dent Clin North Am. 2011 January ; 55(1): 159–178. doi:10.1016/j.cden.2010.08.004. Saliva as a Diagnostic Fluid . Daniel
Malamud, PhDa,b and Isaac R. Rodriguez-Chavez, PhDc
Conclusion
Blood is still the gold standard for diagnostics of diseases and drugs, Saliva offers an alternative to serum
as a biologic fluid for diagnostic purposes
The greatest mile- stone in salivary diagnostics is to identify the disease bio- markers and to transfer it
from the laboratory to the clinical practice.
But the growth of salivary diagnostics has been hindered because of lack of sensitive detection methods,
lack of correlation between the biomolecules in the blood and saliva, and the circadian variations in
saliva.
However, unlike blood and other body fluids, salivary diagnostics offers an easy, inexpensive, painless,
and stress free approach to disease detection.
Reference :
• Shafers textbook of oral pathology
• Tencate’s Oral histology
• Hindawi Publishing Corporation. ISRN Dentistry. Volume 2014, Article ID 158786, 8 pages.
http://dx.doi.org/10.1155/2014/158786 . Review Article . Salivary Diagnostics: A Brief Review. Narasimhan
Malathi,1 Sabesan Mythili,1 and Hannah R. Vasanthi2
• Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC
• Diagnostic Applications of Saliva in Dentistry . 1Prabhakar AR, 2Akanksha Gulati, 3Deepak Mehta, 4Sugandhan S
• Saliva as a diagnostic tool for oral and systemic diseases . Mohammad A. Javaid a, Ahad S. Ahmed b, Robert
Durand c, Simon D. Tran d,*
• Dent Clin North Am. 2011 January ; 55(1): 159–178. doi:10.1016/j.cden.2010.08.004. Saliva as a Diagnostic Fluid.
Daniel Malamud, PhDa,b and Isaac R. Rodriguez-Chavez, PhDc
• IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11,
Issue 6 (Nov.- Dec. 2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr
Shrinivas M Basavaraddi,Dr Krishna Burde, Dr Priya Horatti

Más contenido relacionado

La actualidad más candente (20)

Saliva diagnostic utility
Saliva diagnostic utilitySaliva diagnostic utility
Saliva diagnostic utility
 
Cementum
CementumCementum
Cementum
 
Periodontal ligament
Periodontal ligamentPeriodontal ligament
Periodontal ligament
 
saliva in oral health
 saliva in oral health saliva in oral health
saliva in oral health
 
Trauma from occlusion
Trauma from occlusionTrauma from occlusion
Trauma from occlusion
 
Healing of extraction wound
Healing of extraction woundHealing of extraction wound
Healing of extraction wound
 
Dental Amalgam
Dental AmalgamDental Amalgam
Dental Amalgam
 
Vestibuloplasty
VestibuloplastyVestibuloplasty
Vestibuloplasty
 
Saliva and caries
Saliva and cariesSaliva and caries
Saliva and caries
 
Junctional epithelium
Junctional epitheliumJunctional epithelium
Junctional epithelium
 
Radicular cyst or Periapical cyst
Radicular cyst or Periapical cystRadicular cyst or Periapical cyst
Radicular cyst or Periapical cyst
 
Dental Plaque
Dental PlaqueDental Plaque
Dental Plaque
 
Dentinal hypersensitivity
Dentinal  hypersensitivityDentinal  hypersensitivity
Dentinal hypersensitivity
 
Wedging technique
Wedging techniqueWedging technique
Wedging technique
 
Gingiva
GingivaGingiva
Gingiva
 
periodontal ligament
periodontal ligamentperiodontal ligament
periodontal ligament
 
Junctional epithelium
Junctional epitheliumJunctional epithelium
Junctional epithelium
 
Inflammation: basic concepts
Inflammation: basic conceptsInflammation: basic concepts
Inflammation: basic concepts
 
Caries activity test
Caries activity testCaries activity test
Caries activity test
 
Alveolar bone
Alveolar bone Alveolar bone
Alveolar bone
 

Similar a Diagnostic Potential of Saliva

Similar a Diagnostic Potential of Saliva (20)

Saliva - Diagnostic Tool
Saliva - Diagnostic ToolSaliva - Diagnostic Tool
Saliva - Diagnostic Tool
 
Saliva
SalivaSaliva
Saliva
 
saliva final.pptx
saliva final.pptxsaliva final.pptx
saliva final.pptx
 
saliva 2.ppt
saliva 2.pptsaliva 2.ppt
saliva 2.ppt
 
Saliva final
Saliva finalSaliva final
Saliva final
 
Saliva
SalivaSaliva
Saliva
 
Saliva
Saliva Saliva
Saliva
 
SALIVA.pptx
SALIVA.pptxSALIVA.pptx
SALIVA.pptx
 
SALIVA
SALIVASALIVA
SALIVA
 
saliva final.pptx
saliva final.pptxsaliva final.pptx
saliva final.pptx
 
Saliva BY DR. C. P. ARYA (B.Sc. B.D.S, M.D.S , P.M.S, R.N.T;C.P.)
Saliva BY DR. C. P. ARYA (B.Sc. B.D.S, M.D.S , P.M.S, R.N.T;C.P.)Saliva BY DR. C. P. ARYA (B.Sc. B.D.S, M.D.S , P.M.S, R.N.T;C.P.)
Saliva BY DR. C. P. ARYA (B.Sc. B.D.S, M.D.S , P.M.S, R.N.T;C.P.)
 
Salivary gland disorders, xerostomia
Salivary gland disorders, xerostomiaSalivary gland disorders, xerostomia
Salivary gland disorders, xerostomia
 
saliva final.pptx
saliva final.pptxsaliva final.pptx
saliva final.pptx
 
salivary gland and saliva.pptx
salivary gland and saliva.pptxsalivary gland and saliva.pptx
salivary gland and saliva.pptx
 
Saliva.1
Saliva.1Saliva.1
Saliva.1
 
SALIVA.pptx
SALIVA.pptxSALIVA.pptx
SALIVA.pptx
 
SALIVA AND ITS ROLE IN PROSTHODONTICS.pptx
SALIVA AND ITS ROLE IN PROSTHODONTICS.pptxSALIVA AND ITS ROLE IN PROSTHODONTICS.pptx
SALIVA AND ITS ROLE IN PROSTHODONTICS.pptx
 
Saliva seminar 12
Saliva seminar 12Saliva seminar 12
Saliva seminar 12
 
Saliva - applied physiology and its role in dental caries
Saliva - applied physiology and its role in dental cariesSaliva - applied physiology and its role in dental caries
Saliva - applied physiology and its role in dental caries
 
saliva_7.pptx
saliva_7.pptxsaliva_7.pptx
saliva_7.pptx
 

Más de oral and maxillofacial pathology

Más de oral and maxillofacial pathology (20)

TONGUE ppt
TONGUE pptTONGUE ppt
TONGUE ppt
 
Development of Palate and Tongue PPT
Development of Palate and Tongue PPTDevelopment of Palate and Tongue PPT
Development of Palate and Tongue PPT
 
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPTSQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
 
Levels of Lymph Nodes
Levels of Lymph NodesLevels of Lymph Nodes
Levels of Lymph Nodes
 
DEGLUTTITION (SWALLOWING)
DEGLUTTITION (SWALLOWING)DEGLUTTITION (SWALLOWING)
DEGLUTTITION (SWALLOWING)
 
TONGUE
TONGUETONGUE
TONGUE
 
Trigeminal Nerve
Trigeminal NerveTrigeminal Nerve
Trigeminal Nerve
 
PAGETS DISEASE
PAGETS DISEASEPAGETS DISEASE
PAGETS DISEASE
 
Dental Caries
Dental CariesDental Caries
Dental Caries
 
Lymph Nodes
Lymph NodesLymph Nodes
Lymph Nodes
 
Research Microscopes
Research MicroscopesResearch Microscopes
Research Microscopes
 
Maxillary Second Premolar
Maxillary Second PremolarMaxillary Second Premolar
Maxillary Second Premolar
 
Mandibular Canine
Mandibular CanineMandibular Canine
Mandibular Canine
 
Maxillary Central Incisor
Maxillary Central IncisorMaxillary Central Incisor
Maxillary Central Incisor
 
ENAMEL
ENAMELENAMEL
ENAMEL
 
Developmental Of The Mandible
Developmental Of The MandibleDevelopmental Of The Mandible
Developmental Of The Mandible
 
Developmental Disturbances of The Face
Developmental Disturbances of The FaceDevelopmental Disturbances of The Face
Developmental Disturbances of The Face
 
Development of Face
Development of FaceDevelopment of Face
Development of Face
 
TMJ- 3
TMJ- 3TMJ- 3
TMJ- 3
 
TMJ DISORDER - 2
TMJ DISORDER - 2TMJ DISORDER - 2
TMJ DISORDER - 2
 

Último

epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 

Último (20)

epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 

Diagnostic Potential of Saliva

  • 1. S A L I VA A S A D I A G N O S T I C F L U I D D R A M I T H A G D E P T O F O R A L A N D M A X I L L O FA C I A L PAT H O L O G Y
  • 2. CONTENTS : • Definition • General properties • Composition • Function of saliva • Formation of saliva • Method for collecting saliva • Advantages • Limitations • Analysis of saliva done for the diagnosis of systemic disease
  • 3. Definition: by Stedmann’s & Lipincott medical dictionary. A clear, tasteless, odourless, slightly acidic (pH 6.8) viscous fluid, consisting of the secretion from the parotid, sublingual, submandibular salivary glands and the mucous glands of the oral cavity.
  • 4. General properties • Volume: 1000 to 1500 mL of saliva is secreted per day and, it is approximately about 1 ml/ minute. • Contribution by each major salivary gland is: i. Parotid glands: 25% ii. Submandibular glands: 70% iii. Sublingual glands: 5%. • Reaction: Mixed saliva from all the glands is slightly acidic with pH of 6.35 to 6.85. • Specific gravity: It ranges between 1.002 and 1.012. • Tonicity: Saliva is hypotonic.
  • 5. Salivary flow • The average person produces approximately 0.5 L – 1.5 L per day Unstimulated Flow (resting salivary flow―no external stimulus) • Typically 0.2 mL – 0.3 mL per minute Stimulated Flow (response to a stimulus, usually taste, chewing, or medication [eg, at mealtime]) • Typically 1.5 mL – 2 mL per minute
  • 6. COMPOSITION saliva contains 99.5% water and 0.5%solids.
  • 7. Ten Cate’s Oral Histology
  • 8. Ten Cate’s Oral Histology
  • 9. FUNCTIONS OF SALIVA 1. PROTECTION • Fluid nature of saliva provides a washing action that flushes away non adherent bacteria and other debris. • Helps in clearance of sugars from the mouth limits their availability to acidogenic plaque microorganisms. • Mucins and other glycoproteins provide lubrication, preventing the oral tissues from adhering to one another and allowing them to slide easily over one another. • Mucins also form a barrier against noxious stimuli, microbial toxins, and minor trauma. Ten Cate’s Oral Histology
  • 10. 2. BUFFERING • Bicarbonate and phosphate ions provide a buffering action that helps to protect the teeth from demineralization caused by bacterial acids produced during sugar metabolism. • Some basic salivary proteins also may contribute to the buffering action of saliva. • The metabolism of salivary proteins and peptides by bacteria produces urea and ammonia, which help to increase the pH.
  • 11. 3. PELLICLE FORMATION • Many of the salivary proteins bind to the surfaces of the teeth and oral mucosa, forming a thin film, the salivary pellicle. • Proteins bind calcium and help to protect the tooth surface. • Others have binding sites for oral bacteria, providing the initial attachment for organisms that form plaque.
  • 12. 4. MAINTENANCE OF TOOTH INTEGRITY • Saliva is supersaturated with calcium and phosphate ions. • The solubility of these ions is maintained by several calcium- binding proteins, especially the acidic proline-rich proteins and statherin. • At the tooth surface the high concentration of calcium and phosphate results in a posteruptive maturation of the enamel, increasing surface hardness and resistance to demineralization. • Remineralization of initial caries lesions can occur; this is enhanced by the presence of fluoride ions in saliva.
  • 13. 5. ANTIMICROBIAL ACTION • Saliva contains a spectrum of proteins with antimicrobial activity such as the lysozyme, lactoferrin, peroxidase, and secretory leukocyte protease inhibitor. • A number of small peptides include α-defensins and β-defensins, cathelicidin- LL37,histatins that function by inserting into membranes and disrupting cellular or mitochondrial functions are present in saliva. • These proteins and peptides exhibit antibacterial, antifungal and antiviral activity. • Secretory immunoglobulin A (IgA), causes agglutination of specific microorganisms, preventing their adherence to oral tissues and forming clumps that are swallowed.
  • 14. 6. TISSUE REPAIR • A variety of growth factors and other biologically active peptides and proteins are present in small quantities in saliva. • Many of these substances promote tissue growth and differentiation, wound healing.
  • 15. 7. DIGESTION • The solubilization of food substances and the actions of enzymes such as amylase and lipase begin the digestive process. • The moistening and lubricative properties of saliva also allow the formation and swallowing of a food bolus.
  • 16. 8. TASTE • Saliva solubilize food substances so that they can be sensed by taste receptors located in taste buds. • Saliva produced by minor glands in the vicinity of the circumvallate papillae contains proteins that are believed to bind taste substances and present them to the taste receptors.
  • 17. Formation of saliva occurs in 2 stages. Stage 1 : Production of primary saliva from the cells of secretory end pieces & intercalated ducts, which is an isotonic fluid Stage 2 : The primary saliva is modified as it passes through the striated & excretory ducts mainly by reabsorption & secretion of electrolytes. The final saliva that reaches the oral cavity is hypotonic. FORMATION AND SECRETION OF SALIVA
  • 18. Formation of saliva • acinar cells produce initial saliva composed of water, ions, enzymes, and mucus • initial saliva is isotonic and has approximately same osmolarity as plasma • initial saliva passes from acinus to duct • ductal cells modify initial saliva to produce final saliva by altering various electrolyte concentrations • ductal cells absorb Na+ and Cl-, decreasing ion concentrations in saliva • ductal cells secrete K+ and HCO3 -, increasing ion concentrations in saliva • salivary HCO3 - neutralizes oral bacterial acids • maintains dental health • final saliva is hypotonic and has lower osmolarity than plasma http://www.medbullets.com/step1-gastrointestinal/10023/salivary-secretion
  • 19. Regulation of salivary secretion salivary secretion is stimulated by both sympathetic and parasympathetic nervous systems • sympathetic nervous system • sympathetic input to salivary glands originates in thoracic segments T1-T3 with preganglionic nerves that synapse in superior cervical ganglion • postganglionic sympathetic neurons release norepinephrine (NE) • ↑ NE → stimulates β-adrenergic receptors → stimulates adenylyl cyclase → ↑ cAMP → ↑ saliva secretion • parasympathetic nervous system • parasympathetic input to salivary glands originates in facial nerve (CN VII) and glossopharyngeal nerve (CN IX) • postganglionic parasympathetic neurons release ACh • ↑ ACh → stimulates muscarinic receptors → ↑ IP3 and Ca2+ → ↑ saliva secretion parasympathetic activity stimulated by food, smell, nausea, and conditioning parasympathetic activity inhibited by dehydration, fear, and sleep http://www.medbullets.com/step1-gastrointestinal/10023/salivary-secretion
  • 20. FORMATION AND SECRETION OF SALIVA • Protein secretion occurs by exocytosis, that is, the fusion of secretory granules with the luminal membrane to release their contents into the lumen. • The binding of the sympathetic transmitter norepinephrine (NE) to β-adrenergic (β) receptors on the basolateral membrane activates a heterotrimeric G-protein (Gs), which in turn activates adenylyl cyclase (AC), catalyzing the formation of cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP). • Cyclic adenosine monophosphate activates protein kinase A (PKA), which phosphorylates other proteins in a cascade leading to exocytosis. Ten Cate’s Oral Histology
  • 21. • Fluid and electrolyte secretion is stimulated mainly by the binding of the parasympathetic transmitter, acetylcholine (ACh) to muscarinic cholinergic (MC) receptors and also by norepinephrine binding to α-adrenergic receptors (α). • These receptors activate a heterotrimeric G-protein (Gq/11), causing activation of phospholipase C (PLC), which converts phosphatidylinositol bisphosphate (PIP2) to inositol trisphosphate (IP3) and diacylglycerol (DAG). • Inositol trisphosphate causes the release of Ca2+ from intracellular stores, probably the endoplasmic reticulum. The increased Ca2+ concentration opens Cl– channels in the luminal membrane and K+ channels in the basolateral membrane and activates the basolateral Na+/K+/2Cl– cotransporter.
  • 22. • The increased luminal Cl– is balanced by the movement of extracellular Na++ across the tight junctions (TJ), and the resulting osmotic gradient pulls water into the lumen through the cell via the water channel aquaporin 5 and through the tight junction. • The basolateral Na+/K+/2Cl– cotransporter and the Na+/K+–adenosine triphosphatase serve to maintain the intracellular electrolyte and osmotic balances. • Calcium also stimulates exocytosis, but to a lesser extent than cyclic adenosine monophosphate, and it modulates the activity of protein kinase A and protein kinase C (PKC). Protein kinase C, in turn, modulates exocytosis and intracellular Ca2+ concentrations.
  • 23. Instructions for Collecting Saliva: 1.Remove cap from cryovial 2.Remove Saliva Collection Aid from packaging and place securely into cryovial. 3.Instruct participants to allow saliva to pool in the mouth. 4.With head tilted forward, participants should drool through the SCA to collect saliva in the cryovial. 5.Repeat until sufficient sample is collected. Reserve air space in the vial to accommodate the expansion of saliva during freezing. Collection of samples to be analyzed for multiple analytes may require additional cryovials. 6.Replace cap onto cryovial. How to Collect Saliva: Collection Methods and Devices Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC
  • 24. The Salimetrics Oral Swab (SOS) • If participants are not willing or able to drool saliva into a vial. • If the saliva samples are to be analyzed for cortisol, testosterone, α-amylase, chromogranin A, C-reactive protein, or SIgA, the Salimetrics Oral Swab (SOS) is an excellent alternative to passive drool because of its ease of use. • The SOS also helps filter mucus and other matter from the sample, which may help improve immunoassay results.
  • 25. Collection Methods and Devices: Infants and Small Children The Children’s Swab and Infant’s Swab We recommend the SalivaBio Children’s Swab (SCS) for children under the age of 6, and the SalivaBio Infant’s Swab (SIS) for infants under 6 months of age. The extra-length SalivaBio Children’s Swab (SCS) may also be used for saliva collection from infirmed adult patients to avoid any danger of choking.
  • 26. All SalivaBio swabs are made from the same non-toxic, inert polymer which is guaranteed for consistency across all lots, making it ideal for longitudinal and multi- participant group studies. These devices are manufactured in longer lengths and narrower widths to allow one end of the swab to be held by a parent or technician while the other end is placed in the child’s mouth. The diameters are appropriate for the size of children’s mouths. The polymer material is durable and can withstand chewing, and its taste and texture are also acceptable to children. The volume of sample recovered from the SCS and SIS is typically in the range of 200- 1000 μL. Like the adult SOS, samples collected with either the SCS or the SIS may be tested for various analytes
  • 27. • Passive drool is highly recommended because it is both cost effective and approved for use with almost all analytes. • If participants are not willing or able to drool saliva into a vial, the SalivaBio Oral Swab may be used as an alternative collection method, but only for certain analytes • To avoid problems with analyte retention or the introduction of contaminants, use only high quality polypropylene vials for collection, such as 2 ml cryovials. • The vials used must seal tightly, must be able to withstand temperatures down to -80oC, and must be externally threaded to allow for use of the Saliva Collection Aid to effectively guide drool directly into the cryovial. Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC
  • 28. Advantages 1. Noninvasive diagnosis of disease and monitoring of general health. 2. Painless, patient suffers no discomfort and little anxiety in the collection process. 3. Simple in collection with a modest trained assistant and applicable in remote areas. 4. Relatively cheap technology as compared to other tests. 5. Cost effective applicability for screening large population.
  • 29. 6. Can be used to study special population where blood sampling is a problem e.g children, anxious /handicap/ elderly patients. 7. Convenient for multisampling. 8. Safer for health professionals than blood tests. 9. Compared to blood and urine, saliva is also cheaper to store and ship. 10. In addition saliva does not clot and can be manipulated more easily than blood. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11, Issue 6 (Nov.- Dec. 2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr Shrinivas M Basavaraddi,Dr Krishna Burde, Dr Priya Horatti
  • 30. Limitations: 1. Levels of certain markers in saliva are not always a reliable reflection of the levels of these markers in serum. 2. Salivary composition can be influenced by the method of collection and degree of stimulation of salivary flow. 3. Changes in salivary flow rate may affect the concentration of salivary markers and also their availability due to changes in salivary pH. 4. Variability in salivary flow rate is expected between individuals and in the same individual under different conditions.
  • 31. 6. In addition, many serum markers can reach whole saliva in an unpredictable way (i.e. gingival cervical fluid flow and through oral wounds). These parameters will affect the diagnostic usefulness of many salivary constituents. 7. Furthermore, certain systemic disorders, numerous medications and radiation may affect salivary gland function and consequently the quantity and composition of saliva. 8. Whole saliva also contains proteolytic enzymes derived from the host and from oral microorganisms. These enzymes can affect the stability of certain diagnostic markers. Some molecules are also degraded during intracellular diffusion into saliva. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11, Issue 6 (Nov.- Dec. 2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr Shrinivas M Basavaraddi,Dr Krishna Burde, Dr Priya Horatti
  • 32. Analysis of saliva done for the diagnosis of following Hindawi Publishing Corporation. ISRN Dentistry. Volume 2014, Article ID 158786, 8 pages. http://dx.doi.org/10.1155/2014/158786 . Review Article . Salivary Diagnostics: A Brief Review. Narasimhan Malathi,1 Sabesan Mythili,1 and Hannah R. Vasanthi2
  • 33. Potential Biomarkers in Saliva 1. Autoimmune Diseases A. Sjogren’s Syndrome (SS) • It is an autoimmune disorder characterized by reduced secretion of the salivary glands and lacrimal glands and associated endocrine disturbance. Sialochemistry offers great value in the diagnosis of SS. • An increase in the levels of immunoglobulins, inflammatory mediators, albumin, sodium, and chloride and a decrease in the level of phosphate are indicative of SS. • Salivary protein analysis demonstrated an increased level of lactoferrin, beta 2 microglobulin, lysozyme C, and cystatin C. • The levels of salivary amylase and carbonic anhydrase were decreased.
  • 34. B. Multiple Sclerosis • Multiple sclerosis (MS) is an inflammatory disease characterized by loss of myelin and scarring caused due to destruction/failure of myelin producing cells by the immune system. • Salivary diagnostics shows no significant change in the saliva of patients with multiple sclerosis except for a reduction in IgA production
  • 35. C. Sarcoidosis Sarcoidosis is an inflammatory disease of the lymph nodes, lungs, liver, eyes, skin, or other tissues. Salivary diagnostics demonstrates a decrease in the secretion volume of saliva in addition to a reduction in the enzyme activity of alpha-amylase and kallikrein in most of these patients. However, there was no correlation between the decrease in the enzyme activity and the secretion volume
  • 36. 2. Dental Caries and Periodontal Diseases. • The increased numbers of Streptococcus mutans and lactobacilli in saliva have been associated with increased caries prevalence and root caries. • Periodontal diseases have been associated with increased levels of aspartate aminotransferase (AST) and alkaline phosphatase (ALP). • Salivary AST can be used as a marker for monitoring periodontal disease. • Lower levels of uric acid and albumin were associated with periodontitis and diabetes. This could be attributed to the oxidative stress present in the oral cavity during these conditions. • In patients with type 2 diabetes mellitus, the salivary expression of pIgR, Arp 3, CA VI, and IL-1Ra was down- regulated, whereas PLS-2, LEI, and IGJ chain appeared to be upregulated Diagnostic Applications of Saliva in Dentistry 1Prabhakar AR, 2Akanksha Gulati, 3Deepak Mehta, 4Sugandhan S
  • 37. 3. Malignancy • Tang et al. - lncRNA , p53 protein and miRNAs, - oral squamous cell carcinoma (OSCC) • Salivary lactate dehydrogenase, Salivary cortisol, salivary nitrate and nitrite levels increased - oral cancer • Salivary adenosine deaminase (ADA) activity is significantly increased in squamous cell carcinoma of the tongue progressively from stage I to stage III. • Fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 1 (FGFR1) concentrations in saliva are significantly elevated - salivary gland tumors • Salivary mRNA biomarkers (CCNI, EGFR, FGF19, FRS2, CA 125 and GREB1) - lung cancer • AGPAT1, B2M, BASP2, IER3, and IL1B, CA 125 - ovarian cancer • CA15-3, CA 125 - breast cancer.
  • 38. 4. Bone Turnover Markers: • Saliva can be used in mass screening for metabolic bone disorder. • Human saliva was analysed and there is a significant correlations have been reported between age, body mass index, deoxypyridinium (D-PYR) and osteocalcin (OC) concentration and calcaneus T scores. • This suggests that saliva could be used as a fluid for assay of human biomarkers of bone turnover. • Scannapieco et al. noted a positive association between alveolar bone loss and salivary concentrations of hepatocyte growth factor and interleukin-1 beta. However, there was a negative association between alveolar bone loss and salivary osteonectin. • The increased levels of alkaline phosphatase (ALP) activity in periodontitis have been correlated with the alveolar bone loss
  • 39. 5. Drug Level Monitoring • Saliva is used to detect the presence of nicotine to monitor exposure to tobacco smoke, cannabinoids, cocaine, phencyclidine, opioids, barbiturates, diazepines, amphetamines, and ethanol. • In drug level monitoring, only the unbound fraction of the drug in serum diffuses into the saliva and is detectable in the saliva. • Rapid detection of illicit drug use can also be done through the direct analysis of methamphetamine, cocaine, and 3,4-methylenedioxymethamphetamine in saliva by a hydrophobic porous silicon array. • Saliva is a biological matrix used for drug testing of 𝛾- hydroxybutyric acid (GHB) levels because of its merit of easy, noninvasive collection and stability of the drug. Also, the values of the drug in saliva correlate with its level in the blood
  • 40. 6. Genetic Disorders A. Cystic Fibrosis: • Cystic fibrosis (CF) is a genetically determined condition which is caused due to a mutation in the CFTR gene. • The CFTR protein is expressed in the epithelial cells of the parotid gland causing parotid gland involvement. • The level of activity of cathepsin-D in saliva is significantly higher • The values of sodium, potassium, and chloride concentrations is significantly higher • Salivary calcium concentration, magnesium concentration, and lactate dehydrogenase levels is increased.
  • 41. B. Ectodermal Dysplasia: • The most common form of ectodermal dysplasia is the X-linked hypohidrotic ectodermal dysplasia (HED). • Lexner et al. performed a study on whole saliva flow and composition in males affected by HED and the female carriers. • He found that there was reduced whole saliva flow and the concentration of inorganic constituents and total protein was high. • However, the activity and the concentration of the alpha-amylase in the saliva were reduced
  • 42. 7. Cardiovascular Diseases. • Salivary markers of cardiovascular diseases include C-reactive protein (CRP), myoglobin (MYO), creatinine kinase myocardial band (CK- MB), cardiac troponins (cTn), and myeloperoxidase, which, when used in combination with an ECG, shows a positive correlation with myocardial infarct patients as compared to healthy controls. • The salivary MYO levels are significantly higher within 48 h of onset of chest pain in acute myocardial infarction (AMI) patients. • In a study performed by Miller et al., In AMI they found that the salivary concentrations of CRP, TNF-𝛼, and MMP-9 were higher salivary myeloperoxidase and salivary soluble ICAM-1levels elevated salivary soluble CD40 ligand is lower • Increased levels of salivary lysozyme have been shown to be associated with hypertension, an early stage of cardiovascular disorders
  • 43. 8. Infections (1) Viral infections : Measles virus-specific IgM, HIV—HIV-1, HIV-2—antibodies, salivary proteins (2) Bacterial infections : Mycobacterium tuberculosis, MUC 5B, and MUC 7 (3) Fungal infections : Candidiasis immunoglobulins, Hsp 70, and calprotectin, histatins, mucins, basic proline rich proteins, and peroxidases
  • 44. 9. Psychological research Salivary amylase, cortisol, substance P, lysozyme, secretory IgG, and testosterone 10. Renal diseases Cortisol, nitrite, uric acid, sodium chloride, pH, alpha-amylase, and lactoferrin. Salivary phosphate, serum creatinine, and glomerular ltration rate 11. Diseases of the adrenal cortex Salivary cortisol Dent Clin North Am. 2011 January ; 55(1): 159–178. doi:10.1016/j.cden.2010.08.004. Saliva as a Diagnostic Fluid . Daniel Malamud, PhDa,b and Isaac R. Rodriguez-Chavez, PhDc
  • 45.
  • 46.
  • 47. Conclusion Blood is still the gold standard for diagnostics of diseases and drugs, Saliva offers an alternative to serum as a biologic fluid for diagnostic purposes The greatest mile- stone in salivary diagnostics is to identify the disease bio- markers and to transfer it from the laboratory to the clinical practice. But the growth of salivary diagnostics has been hindered because of lack of sensitive detection methods, lack of correlation between the biomolecules in the blood and saliva, and the circadian variations in saliva. However, unlike blood and other body fluids, salivary diagnostics offers an easy, inexpensive, painless, and stress free approach to disease detection.
  • 48. Reference : • Shafers textbook of oral pathology • Tencate’s Oral histology • Hindawi Publishing Corporation. ISRN Dentistry. Volume 2014, Article ID 158786, 8 pages. http://dx.doi.org/10.1155/2014/158786 . Review Article . Salivary Diagnostics: A Brief Review. Narasimhan Malathi,1 Sabesan Mythili,1 and Hannah R. Vasanthi2 • Saliva Collection and Handling Advice 2nd Edition Copyright 2011, Salimetrics, LLC • Diagnostic Applications of Saliva in Dentistry . 1Prabhakar AR, 2Akanksha Gulati, 3Deepak Mehta, 4Sugandhan S • Saliva as a diagnostic tool for oral and systemic diseases . Mohammad A. Javaid a, Ahad S. Ahmed b, Robert Durand c, Simon D. Tran d,* • Dent Clin North Am. 2011 January ; 55(1): 159–178. doi:10.1016/j.cden.2010.08.004. Saliva as a Diagnostic Fluid. Daniel Malamud, PhDa,b and Isaac R. Rodriguez-Chavez, PhDc • IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861. Volume 11, Issue 6 (Nov.- Dec. 2013), PP 96-99 www.iosrjournals.org Saliva- A Diagnostic Tool. Dr Vijaylaxmi B Madalli, Dr Shrinivas M Basavaraddi,Dr Krishna Burde, Dr Priya Horatti

Notas del editor

  1. HCO3 - hydrogen carbonate
  2. Arp 3 protein complex (orange colour) - regulation of actin cytoskeleton
  3. long noncoding RNA (lncRNA)